Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Psychedelic Research
Ultra-Low-Dose Ketamine May Offer Relief For Opioid Withdrawal, Study Finds
Magic Mushrooms Boosted Humanity's Evolutionary Success, New Study Says: Did Psilocybin Make Early Humans Better Hunters?
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
Magic Mushrooms Boosted Humanity's Evolutionary Success, New Study Says: Did Psilocybin Make Early Humans Better Hunters?
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
LSD, MDMA And d-Amphetamine: Study Provides New Insights Into Neurobiological Effects
PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract
LSD, MDMA And d-Amphetamine: Study Provides New Insights Into Neurobiological Effects
PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract
Moxy: The Short, Intense Psychedelic High Sweeping The Globe
Psilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive Effects
Read More...
Psychedelic Research Recent News
How Set And Setting Impact The Effects Of LSD, New Study Sheds Light
New research finds that LSD effects are shaped by dose, mood, and personality traits, offering insights into optimizing psychedelic therapy.
Psychedelic Therapy Needs To Move Beyond Mystical Experiences, Say Researchers In New Study
Explore new insights into the therapeutic potential of psychedelics beyond mystical experiences and their impact on clinical outcomes.
Single-Dose Psilocybin Therapy Shows Promise For Treating Alcohol Use Disorder, Study Finds
New study shows single-dose psilocybin therapy may reduce alcohol consumption in alcohol use disorder patients, offering a promising new treatment approach.
Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD
MAPS funds a $200K pilot study at Emory University exploring the synergy between MDMA-assisted therapy and Massed Exposure Therapy for PTSD.
Psychedelic Trips Resemble Near-Death Experiences, New Study Shows—What Does It Mean?
New research highlights significant overlap between near-death experiences and those induced by psychedelic drugs, offering fresh insights into the nature of consciousness.
Psychedelics Enhance Creativity After Use, But MDMA Disrupts Memory, Study Shows
New research reveals distinct cognitive effects of psychedelics and MDMA, showing that psychedelics may impair focus but boost creativity, while MDMA primarily disrupts memory.
LSD's Potential In Pain Management: New Research Sheds Light On Psychedelic's Influence On Brain Networks
New research reveals how LSD alters brain networks involved in pain processing, offering potential insights for future pain management strategies.
MDMA Therapy Papers Retracted Amid Ethical Concerns At Lykos Study Site
Psychopharmacology retracts MDMA therapy papers due to ethical misconduct, while Lykos Therapeutics faces FDA rejection for PTSD treatment application.
New Tool Tracks Psychedelic Effects In Brain Neurons In Minutes Rather Than Hours
UC Davis researchers develop CaST, a rapid tool to track neurons affected by psychedelics, offering new insights into treatments for depression and PTSD.
FDA Clears Incannex To Proceed With Phase 2 Psilocybin-Assisted Therapy Trial For Anxiety
FDA approves Incannex's Phase 2 trial for psilocybin-assisted psychotherapy in treating generalized anxiety disorder, following a successful review of the IND application.
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Can Psychedelics Increase Sexual Interest And Satisfaction? Study Says Yes And Effects Can Last Months
US Universities Ride The Psychedelics Wave With New Programs In Their Medical Schools
West Coast’s New Psychedelics & Neurotherapeutics Institute The University of California (UC) Davis launched the Institute for Psychedelics and Neurotherapeutics to further knowledge of how psychedelics work and produce safe and effective treatments for a range of mental health conditions.
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and further guidance for pre-clinical research and studies with young participants.
EXCLUSIVE: MAPS To Host Major Psychedelics Event In 2023, Speakers & Details Below
The Multidisciplinary Association for Psychedelic Studies (MAPS) has shared details for its Psychedelic Science 2023 event taking place next June 19 to 23 in Denver, Colorado.
Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More
LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon
UCSF Launches New Psychedelic Research Division
This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission.